Omnicef

Moraxella catarrhalis, Tonsillitis, Tonsillitis + 19 more

Treatment

22 FDA approvals

9 Active Studies for Omnicef

Treatment for

Moraxella catarrhalis

What is Omnicef

CefdinirThe Generic name of this drug

Treatment SummaryOmnicef (cefdinir) is a type of antibiotic used to treat bacterial infections in the ear, sinus, throat, lungs, and skin. It belongs to the third generation of cephalosporin antibiotics and was approved by the FDA in 1997. Omnicef is effective against bacteria that are resistant to other types of antibiotics due to their production of beta-lactamase enzymes.

Omnicefis the brand name

image of different drug pills on a surface

Omnicef Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Omnicef

Cefdinir

1997

175

Approved as Treatment by the FDA

Cefdinir, also known as Omnicef, is approved by the FDA for 22 uses including Bronchitis and Acute Exacerbations of Chronic Bronchitis caused by Haemophilus Influenza .

Bronchitis

Acute Exacerbations of Chronic Bronchitis caused by Haemophilus Influenza

Maxillary Sinusitis

Tonsillitis

Bronchitis, Chronic

Haemophilus parainfluenzae

Uncomplicated skin and skin structure infections caused by streptococcus pyogenes, staphylococcus aureus

Acute exacerbation of chronic bronchitis caused by Haemophilus parainfluenzae

Haemophilus influenzae

Tonsillitis streptococcal

Haemophilus influenzae

Acute maxillary sinusitis caused by Susceptible strains of Streptococcus pneumoniae

Acute maxillary sinusitis caused by H. influenzae

Streptococcal Pharyngitis

acute otitis media caused by S.pneumoniae

Acute Exacerbation of Chronic Bronchitis caused by Streptococcus Pneumoniae

Moraxella catarrhalis

Acute maxillary sinusitis caused by M. catarrhalis

Moraxella catarrhalis

Community acquired pneumonia caused by Susceptible strains of Streptococcus pneumoniae

Bronchitis

Moraxella catarrhalis

Effectiveness

How Omnicef Affects PatientsCefdinir is a type of medicine that kills bacteria and prevents them from multiplying. It is effective against a wide range of gram-positive and gram-negative bacteria, including those that are resistant to other cephalosporins. Cefdinir works by stopping the bacteria from building their cell walls, which helps to stop them from spreading.

How Omnicef works in the bodyCefdinir attacks bacteria in a similar way to other beta-lactam antibiotics. It works by binding to proteins that help form the bacterial cell wall. By doing this, it interferes with the cell wall's formation, which leads to cell death. Cefdinir has a stronger effect than penicillin because it has a 6-member dihydrothiazine ring instead of the 5-member thiazolidine ring found in penicillin. This 6-member ring helps the drug resist inactivation by certain bacterial enzymes and binds to penicillin-binding proteins. In addition, cefdinir

When to interrupt dosage

The measure of Omnicef is contingent upon the diagnosed disorder, including Communicable Diseases, Bronchitis and Haemophilus parainfluenzae. The magnitude of dosage is contingent upon the approach of delivering the drug (e.g. Capsule or Capsule - Oral) as outlined in the table beneath.

Condition

Dosage

Administration

Bronchitis

300.0 mg, , 125.0 mg/mL, 250.0 mg/mL